Clinical Trial Update: Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis

View source ↗

Summary

This update reports the completion of a clinical trial validating a risk stratification score for idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Idiopathic Pulmonary Fibrosis | Status: COMPLETED